Skip to content

Drug interactions

Erlotinib + Fluvoxamine

Severity: Moderate

Erlotinib and Fluvoxamine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erlotinib is metabolized mainly by CYP3A4 and partly by CYP1A2, and fluvoxamine inhibits CYP1A2 strongly and CYP3A4 weakly. Erlotinib exposure may increase, raising the risk of rash, diarrhea and other dose-related toxicity.

What this interaction means in plain words

Erlotinib and Fluvoxamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erlotinib belongs to Oncology; Fluvoxamine belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Fluvoxamine inhibits CYP1A2 and CYP3A4, reducing erlotinib clearance.

What to do

Monitor for rash, diarrhea and interstitial lung symptoms, and reduce the erlotinib dose stepwise if severe reactions occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erlotinib and Fluvoxamine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erlotinib with Fluvoxamine?

MediHelp rates the interaction as moderate. Erlotinib and Fluvoxamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erlotinib is metabolized mainly by CYP3A4 and partly by CYP1A2, and fluvoxamine inhibits CYP1A2 strongly and CYP3A4 weakly. Erlotinib exposure may increase, raising the risk of rash, diarrhea and other dose-related toxicity.

How serious is the interaction between Erlotinib and Fluvoxamine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for rash, diarrhea and interstitial lung symptoms, and reduce the erlotinib dose stepwise if severe reactions occur.

What other medicines interact with Fluvoxamine?

MediHelp also lists interactions of Fluvoxamine with, for example, Agomelatine, Alosetron, Fezolinetant. The full list is on the Fluvoxamine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in